Literature DB >> 18416448

Consultants' forum: should post hoc sample size calculations be done?

Stephen J Walters1.   

Abstract

Pre-study sample size calculations for clinical trial research protocols are now mandatory. When an investigator is designing a study to compare the outcomes of an intervention, an essential step is the calculation of sample sizes that will allow a reasonable chance (power) of detecting a pre-determined difference (effect size) in the outcome variable, at a given level of statistical significance. Frequently studies will recruit fewer patients than the initial pre-study sample size calculation suggested. Investigators are faced with the fact that their study may be inadequately powered to detect the pre-specified treatment effect and the statistical analysis of the collected outcome data may or may not report a statistically significant result. If the data produces a "non-statistically significant result" then investigators are frequently tempted to ask the question "Given the actual final study size, what is the power of the study, now, to detect a treatment effect or difference?" The aim of this article is to debate whether or not it is desirable to answer this question and to undertake a power calculation, after the data have been collected and analysed. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 18416448     DOI: 10.1002/pst.334

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  20 in total

1.  Evidence bicycle helmets mitigate intra-cranial injury is not controversial.

Authors:  J Olivier; P Creighton; C T Mason
Journal:  Eur J Trauma Emerg Surg       Date:  2016-01-22       Impact factor: 3.693

2.  Hydroxyethyl starch 130/0.42 for bolus resuscitation in severe sepsis: long-term follow-up, confidence intervals and clinically important differences in outcomes.

Authors:  Gordon S Doig; Fiona Simpson
Journal:  Intensive Care Med       Date:  2014-05-20       Impact factor: 17.440

3.  Endonasal dacryocystorhinostomy with and without stenting.

Authors:  M I Syed; J Hendry; A J Cain; A T Williams
Journal:  Ann R Coll Surg Engl       Date:  2014-03       Impact factor: 1.891

4.  Is inconsistent pre-treatment bedtime related to CPAP non-adherence?

Authors:  Amy M Sawyer; Tonya S King; Douglas A Sawyer; Albert Rizzo
Journal:  Res Nurs Health       Date:  2014-10-29       Impact factor: 2.228

5.  Daily Lowest Hemoglobin and Risk of Organ Dysfunctions in Critically Ill Patients.

Authors:  Sarah J Hemauer; Adam J Kingeter; Xue Han; Matthew S Shotwell; Pratik P Pandharipande; Liza M Weavind
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

6.  A statistical assessment of differences and equivalences between genetically modified and reference plant varieties.

Authors:  Hilko van der Voet; Joe N Perry; Billy Amzal; Claudia Paoletti
Journal:  BMC Biotechnol       Date:  2011-02-16       Impact factor: 2.563

7.  Mixed Modal Training to Help Older Adults Maintain Postural Balance.

Authors:  Amanda Marchini; Wellington Pedroso; Osmar Pinto Neto
Journal:  J Chiropr Med       Date:  2020-08-21

8.  Differences in the magnetic resonance imaging parameter T2* may be identified during the course of canine patellar tendon healing: a pilot study.

Authors:  Sarah L Pownder; Kei Hayashi; Bin Q Lin; Kathleen N Meyers; Brian G Caserto; Ryan E Breighner; Hollis G Potter; Matthew F Koff
Journal:  Quant Imaging Med Surg       Date:  2021-04

9.  Telomere length and long-term endurance exercise: does exercise training affect biological age? A pilot study.

Authors:  Ida Beate Ø Østhus; Antonella Sgura; Francesco Berardinelli; Ingvild Vatten Alsnes; Eivind Brønstad; Tommy Rehn; Per Kristian Støbakk; Håvard Hatle; Ulrik Wisløff; Javaid Nauman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study.

Authors:  Yipin Zhao; Huawei Wang; Dazhi Ke; Wei Deng; Yingying Ji; Jiaojiao Yang; Zebin Lin; Guoxing Li; Li Xiao; Jianmin Tang; Qingwei Chen
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.